agilon health, inc. (NYSE:AGL) Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp reduced its position in agilon health, inc. (NYSE:AGL - Free Report) by 9.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 774,802 shares of the company's stock after selling 77,150 shares during the period. Bank of New York Mellon Corp owned 0.19% of agilon health worth $1,472,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. JPMorgan Chase & Co. boosted its stake in agilon health by 326.4% in the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock valued at $5,563,000 after acquiring an additional 1,083,492 shares in the last quarter. Inspire Investing LLC increased its position in agilon health by 106.6% during the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company's stock valued at $413,000 after buying an additional 112,241 shares in the last quarter. Citigroup Inc. raised its stake in agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company's stock valued at $7,971,000 after buying an additional 1,941,993 shares during the last quarter. Geode Capital Management LLC boosted its holdings in agilon health by 1.2% in the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company's stock worth $27,097,000 after acquiring an additional 84,889 shares in the last quarter. Finally, Empowered Funds LLC purchased a new stake in shares of agilon health during the fourth quarter worth about $97,000.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on AGL shares. Macquarie assumed coverage on shares of agilon health in a research note on Monday, December 16th. They issued a "neutral" rating and a $3.00 target price for the company. Stifel Nicolaus lifted their price objective on shares of agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a research note on Wednesday, February 26th. Needham & Company LLC reissued a "hold" rating on shares of agilon health in a report on Friday, March 21st. Royal Bank of Canada raised their target price on agilon health from $3.00 to $3.50 and gave the stock an "outperform" rating in a research note on Wednesday, February 26th. Finally, Sanford C. Bernstein boosted their price target on agilon health from $2.50 to $3.15 and gave the company a "market perform" rating in a research note on Wednesday, January 15th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, agilon health has a consensus rating of "Hold" and a consensus target price of $3.95.

Remove Ads

agilon health Price Performance

Shares of NYSE AGL traded up $0.05 during trading on Wednesday, hitting $4.53. 3,125,792 shares of the company were exchanged, compared to its average volume of 4,610,080. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health, inc. has a 1 year low of $1.50 and a 1 year high of $7.73. The company has a market cap of $1.87 billion, a price-to-earnings ratio of -4.82 and a beta of 0.67. The firm's fifty day moving average price is $3.58 and its 200 day moving average price is $2.95.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.